Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
41
CTVA Quote, Financials, Valuation and Earnings
Last price:
$67.30
Seasonality move
:
6.73%
Day range:
$66.50 - $67.23
52-week range:
$53.40 - $77.41
Dividend yield:
1.04%
P/E ratio:
28.67x
P/S ratio:
2.63x
P/B ratio:
1.80x
Volume:
2.6M
Avg. volume:
3.8M
1-year change:
17.97%
Market cap:
$45.4B
Revenue:
$16.9B
EPS (TTM):
$2.34
Earnings Data
Next earnings date for CTVA
Feb 04
2026
Most recent earnings per share
-$0.47
Missed by $0.01
(Nov 4/2025)
Consensus Estimate
-$0.47
(Nov 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CTVA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/04/2026 | Q4 | $4.2B | -- | -- | $0.21 | -- |
| 11/04/2025 | Q3 | $2.5B | $2.6B | -$0.47 | -$0.47 | -$0.01 |
| 08/06/2025 | Q2 | $6.3B | $6.5B | $1.92 | $1.88 | $0.04 |
| 05/07/2025 | Q1 | $4.5B | $4.4B | $0.95 | $0.88 | $0.07 |
| 02/05/2025 | Q4 | $4B | $4B | -$0.06 | $0.31 | -$0.37 |
| 11/06/2024 | Q3 | $2.7B | $2.3B | -$0.76 | -$0.30 | -$0.46 |
| 07/31/2024 | Q2 | $6.2B | $6.1B | $1.51 | $1.72 | -$0.21 |
| 05/01/2024 | Q1 | $4.6B | $4.5B | $0.60 | $0.83 | -$0.23 |
| 01/31/2024 | Q4 | $3.6B | $3.7B | -$0.36 | $0.06 | -$0.42 |
| 11/08/2023 | Q3 | -- | -- | -$0.45 | -$0.26 | -$0.19 |
| 08/03/2023 | Q2 | -- | -- | $1.00 | $1.58 | -$0.58 |
| 05/03/2023 | Q1 | -- | -- | $0.83 | $0.93 | -$0.10 |
| 02/01/2023 | Q4 | -- | -- | -$0.08 | $0.06 | -$0.14 |
| 11/03/2022 | Q3 | -- | -- | -$0.46 | -$0.22 | -$0.24 |
| 08/04/2022 | Q2 | -- | -- | $1.33 | $1.46 | -$0.13 |
| 05/04/2022 | Q1 | -- | -- | $0.78 | $0.81 | -$0.03 |
| 02/02/2022 | Q4 | -- | -- | $0.22 | $0.09 | $0.13 |
| 11/04/2021 | Q3 | -- | -- | $0.04 | -$0.31 | $0.35 |
| 08/05/2021 | Q2 | -- | -- | $1.31 | $1.27 | $0.04 |
| 05/04/2021 | Q1 | -- | -- | $0.80 | $0.65 | $0.15 |
| 02/04/2021 | Q4 | -- | -- | $0.05 | -$0.04 | $0.09 |
| 11/06/2020 | Q3 | -- | -- | -$0.52 | -$0.42 | -$0.10 |
| 07/30/2020 | Q2 | -- | -- | $1.01 | $1.24 | -$0.23 |
| 05/07/2020 | Q1 | -- | -- | $0.36 | $0.39 | -$0.03 |
| 01/30/2020 | Q4 | -- | -- | -$0.03 | -$0.12 | $0.09 |
| 10/31/2019 | Q3 | -- | -- | -$0.66 | -$0.45 | -$0.21 |
| 08/01/2019 | Q2 | -- | -- | -$0.81 | $1.02 | -$1.83 |
| 03/31/2019 | Q1 | -- | -- | $0.22 | $0.44 | -$0.22 |
| 12/31/2018 | Q4 | -- | -- | -$0.71 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$6.83 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.93 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.29 | -- | -- |
Corteva, Inc. Earnings Questions
-
How Much did Corteva, Inc. Generate in Revenue Last Quarter?
Corteva, Inc. reported $2.6B worth of top line sales in its most recent quarter.
-
Did Corteva, Inc. Beat Earnings Last Quarter?
Corteva, Inc. announced earnings per share of -$0.47 which represents a miss of analyst forecast a -$0.47 per share.
-
Is Corteva, Inc. Profitable?
Corteva, Inc. reported $777M that represents $1.14 per share over the last quarter.
-
What is the Analyst Consensus for Corteva, Inc. EPS Next Year?
Corteva, Inc.'s earnings are forecast to grow from $1.30 per share to $2.55 per share next year representing an increase of 155.63%.
-
When is Corteva, Inc.'s Earnings Date?
Corteva, Inc.'s next earnings date is February 4, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
